Oxaloacetate (OAA)

DIETARY_SUPPLEMENT2 trials

Sponsors

University of Kansas Medical Center, Russell Swerdlow, MD

Conditions

Alzheimer's DiseaseParkinson's Disease

Phase 2

A Pilot Study of Oxaloacetate in Subjects With Treated PD

CompletedNCT01741701

University of Kansas Medical CenterParkinson's Disease

Start: 2012-12-31End: 2014-10-31Updated: 2016-03-17

Unknown Phase

Oxaloacetate Pharmacokinetics and Safety

CompletedNCT02063308

Russell Swerdlow, MDAlzheimer's Disease

Start: 2014-02-28End: 2014-06-30Updated: 2014-07-24